Kala Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update

Go back to Kala Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
(NASDAQ: KALA) Delayed: 0.32 -0.04 (11.11%)
Previous Close $0.36    52 Week High $ 
Open $0.35    52 Week Low $ 
Day High $0.35    P/E N/A 
Day Low $0.32    EPS $ 
Volume 217,058